Recent advances in understanding and managing chordomas: an update

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Chordomas are rare, challenging tumors originating from the embryonic notochord.
• Current surgical treatments often result in high recurrence rates and low disease-free survival.
• Advanced therapeutic strategies are needed to improve patient prognosis.

Purpose of the Study:

• To review the current treatment landscape for chordomas.
• To highlight emerging adjuvant therapies and their potential impact.
• To emphasize the importance of a multidisciplinary approach in managing chordoma.

Main Methods:

• Review of current literature on chordoma treatment.
• Analysis of advancements in genetics, targeted molecular therapy, and radiation therapy.
• Discussion of the role of a multidisciplinary team in patient care.

Main Results:

• Surgery remains the primary treatment, but often insufficient for complete cure.
• Genetics, targeted molecular therapy, and heavy-particle beam therapy show potential as adjuvant treatments.
• Multidisciplinary care is crucial for optimizing outcomes.

Conclusions:

• Chordoma management requires a comprehensive strategy beyond surgery.
• Integration of novel therapies and specialized care can improve survival and quality of life.
• Further research into targeted treatments and immunotherapy is warranted.